Corinna zur Bonsen-Thomas

About Corinna zur Bonsen-Thomas

Corinna zur Bonsen-Thomas is an experienced healthcare and biotech executive with a profile that combines corporate legal expertise, board governance, and operational leadership across pharmaceuticals, medical devices, and digital health. At Abivax, the listed biopharmaceutical company focused on chronic inflammatory diseases, she held prominent governance responsibilities, including serving as interim Chair of the Board from August 2022 before returning to her role as a Board member. Abivax’s current governance pages show that she remains a Board member and serves on the Audit Committee. Her professional background spans more than 30 years of leadership experience. Abivax describes her as having held various vice-presidential roles in the global pharmaceutical and medical device industries, as well as in digital health startups. She is also the co-founder and CEO of RetInSight, a digital health company, and previously served as General Counsel at Baxter/Baxalta International. That combination points to a career built on legal oversight, corporate governance, regulatory discipline, and the scaling of innovative healthcare businesses. Within Abivax, her role was especially significant during the company’s governance transition in 2022 and 2023. The company announced her appointment as interim Chair and later the appointment of Marc de Garidel as CEO and interim Board Chair, while confirming that Corinna zur Bonsen-Thomas would continue as a Board member. This suggests that she played an important part in ensuring board continuity, governance stability, and strategic alignment during a sensitive leadership change for a publicly listed biotech company. More broadly, she is a seasoned independent director with extensive supervisory board experience and committee work. Her expertise is particularly relevant to companies operating in highly regulated environments, where legal rigor, risk management, and long-term strategic thinking are essential. Her profile reflects a governance-minded executive who supports innovation while maintaining strong oversight standards.